Omission in Additional Information
- PMID: 30973605
- DOI: 10.1001/jamaoncol.2019.0708
Omission in Additional Information
Erratum for
-
Evaluating Risks and Benefits of Evolving Systemic Treatments of Neuroendocrine Tumors.JAMA Oncol. 2019 Apr 1;5(4):489-490. doi: 10.1001/jamaoncol.2018.6694. JAMA Oncol. 2019. PMID: 30763444 No abstract available.
Publication types
LinkOut - more resources
Full Text Sources